AAV9 vectors encoding non-self proteins can provoke significant cell-mediated and humoral immune responses in the brain, complicating preclinical toxicology studies.
No takes yet. Share an insight, caveat, or question.
AAV9 vectors encoding non-self proteins may trigger neuroinflammation and neuronal loss in the brain; leaves open optimal vector selection for CNS gene therapy trials.
Ciesielska et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: